Bariatric Times

APR 2018

A peer-reviewed, evidence-based journal that promotes clinical development and metabolic insights in total bariatric patient care for the healthcare professional

Issue link: https://bariatrictimes.epubxp.com/i/958707

Contents of this Issue

Navigation

Page 18 of 28

18 Ask the Leadership Bariatric Times • April 2018 American Society for Metabolic and Bariatric Surgery (ASMBS) Approves Intragastric Balloon Bariatric Times. 2018;15(4):18–19. What are your initial thoughts on the ASMBS adding the intragastric balloon to its list of approved devices and procedures? Dr. Mattar: I am very pleased that we have expanded our portfolio of options, as part of the continuum of care, we can offer our patients. Everyone gains, especially our patients, when additional procedures or devices that have been adequately evaluated for safety and efficacy are added to our armamentarium. What were the steps for gaining official approval for the intragastric balloon? Dr. Mattar: The process begins when an application (available on the ASMBS website) is submitted by an ASMBS member advocating for the approval of a procedure or device. The application is then reviewed by the Executive Committee of the Executive Council (ECEC), followed by the New Devices and Procedures Task Force, a group that includes representation from the top ASMBS leadership— Clinical Issues Committee (CIC), Insurance Committee, and Research Committee. Here the topic is deliberated and evaluated for substance and validity. Following a positive recommendation from the task force, the issue is presented to the ECEC in a pro/con debate format (presented by guest experts) along with a brief review of pertinent scientific data from a member of the CIC. If approved, the matter is then released as a survey to solicit opinions from the entire ASMBS membership. The survey results are analyzed by the ECEC, which then votes. A 75-percent majority vote is needed for final approval. Insurance coverage continues to be a key issue regarding bariatric surgery. Do you think now that the ASMBS has gained momentum in getting other forms of bariatric surgery covered by insurance companies it will be easier to accelerate coverage for the balloon too? Dr. Mattar: As you can see, the ASMBS approval mechanism is thorough and rigorous, based on scientific data, free and ample deliberation at many levels, and most importantly, reliant on input from the entire membership. Thus the approval of a new device or procedure by ASMBS affords this item the full weight and influence of our society and forges the path to acceptance and validation by many stakeholders, including payers and regulatory bodies. How quickly do you think the intragastric balloon will be adopted by bariatric surgeons nationwide? Is there any learning curve for bariatric surgeons who haven't done this procedure before? Dr. Mattar: Any new technology carries an inherent learning curve, and we are satisfied that the current process adopted by the balloon manufacturers includes a training mechanism before practitioners are provided with the balloons. But, first and foremost, we are firm, adamant, and resolute in our calling that all patients who receive any component of our continuum of care should do so within the confines of a multidisciplinary team that is patient- centric and focused on optimizing the chances for their durable and holistic improvement. Do you think it will be easier to convince patients that the balloon is the right choice for them since it's a nonsurgical option? Dr. Mattar: I think I share the same approach with all my colleagues in the field, in that I don't really try to "convince" the patient of a particular procedure or device. I have learned that patients do best when they genuinely and actively "embrace" a procedure, rather than passively agree to accept what is offered. I present all the updated information regarding the proven efficacy, safety, risks, benefits, and expectations of a procedure and then help the patient reach an informed decision that we both agree is the most appropriate with regard to his or her particular characteristics. An inter view with: Samer Mattar, MD, FACS, FRCS, FASMBS Medical Director, Swedish Weight Loss Services in Seattle, Washington, President of the American Society for Metabolic and Bariatric Surgery (ASMBS) T he ASMBS officially approved the intragastric balloon for bariatric surgery. The announcement was made February 5, 2018. The intragastric balloon was first approved by the United States Food and Drug Administration (FDA) in 2015 for patients with a body mass index (BMI) between 30 and 40kg/m 2 . The balloon, which is filled with saline, is endoscopically placed into a patient's stomach with the intention of filling up a portion of the stomach and making patients feel full more quickly. The device remains in a patient for six months before it is removed. Approximately 5,000 intragastric balloons have been implanted since 2015, a small portion of the total bariatric surgeries that have been completed in the United States. Patients who choose to have a balloon are required to go through a strict diet while the balloon is in their body as well as after it is removed. The other six ASMBS-approved devices and procedures, thus far, are Roux-en-Y gastric bypass, duodenal switch, sleeve gastrectomy, adjustable gastric banding, bariatric reoperative procedures, and open procedures (when deemed appropriate by the surgeon). This column is dedicated to sharing the vast knowledge and opinions of the American Society for Metabolic and Bariatric Surgery (ASMBS) leadership—past and present—on relevant topics in the field of bariatric surgery.

Articles in this issue

Archives of this issue

view archives of Bariatric Times - APR 2018